Literature DB >> 28331092

Monkeypox Virus Host Factor Screen Using Haploid Cells Identifies Essential Role of GARP Complex in Extracellular Virus Formation.

Susan Realegeno1, Andreas S Puschnik2, Amrita Kumar3, Cynthia Goldsmith4, Jillybeth Burgado1, Suryaprakash Sambhara3, Victoria A Olson1, Darin Carroll1, Inger Damon1, Tetsuya Hirata5, Taroh Kinoshita5, Jan E Carette6, Panayampalli Subbian Satheshkumar7.   

Abstract

Monkeypox virus (MPXV) is a human pathogen that is a member of the Orthopoxvirus genus, which includes Vaccinia virus and Variola virus (the causative agent of smallpox). Human monkeypox is considered an emerging zoonotic infectious disease. To identify host factors required for MPXV infection, we performed a genome-wide insertional mutagenesis screen in human haploid cells. The screen revealed several candidate genes, including those involved in Golgi trafficking, glycosaminoglycan biosynthesis, and glycosylphosphatidylinositol (GPI)-anchor biosynthesis. We validated the role of a set of vacuolar protein sorting (VPS) genes during infection, VPS51 to VPS54 (VPS51-54), which comprise the Golgi-associated retrograde protein (GARP) complex. The GARP complex is a tethering complex involved in retrograde transport of endosomes to the trans-Golgi apparatus. Our data demonstrate that VPS52 and VPS54 were dispensable for mature virion (MV) production but were required for extracellular virus (EV) formation. For comparison, a known antiviral compound, ST-246, was used in our experiments, demonstrating that EV titers in VPS52 and VPS54 knockout (KO) cells were comparable to levels exhibited by ST-246-treated wild-type cells. Confocal microscopy was used to examine actin tail formation, one of the viral egress mechanisms for cell-to-cell dissemination, and revealed an absence of actin tails in VPS52KO- or VPS54KO-infected cells. Further evaluation of these cells by electron microscopy demonstrated a decrease in levels of wrapped viruses (WVs) compared to those seen with the wild-type control. Collectively, our data demonstrate the role of GARP complex genes in double-membrane wrapping of MVs necessary for EV formation, implicating the host endosomal trafficking pathway in orthopoxvirus infection.IMPORTANCE Human monkeypox is an emerging zoonotic infectious disease caused by Monkeypox virus (MPXV). Of the two MPXV clades, the Congo Basin strain is associated with severe disease, increased mortality, and increased human-to-human transmission relative to the West African strain. Monkeypox is endemic in regions of western and central Africa but was introduced into the United States in 2003 from the importation of infected animals. The threat of MPXV and other orthopoxviruses is increasing due to the absence of routine smallpox vaccination leading to a higher proportion of naive populations. In this study, we have identified and validated candidate genes that are required for MPXV infection, specifically, those associated with the Golgi-associated retrograde protein (GARP) complex. Identifying host targets required for infection that prevents extracellular virus formation such as the GARP complex or the retrograde pathway can provide a potential target for antiviral therapy.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  GARP complex; HAP1 screen; poxviruses; retrograde transport

Mesh:

Substances:

Year:  2017        PMID: 28331092      PMCID: PMC5432867          DOI: 10.1128/JVI.00011-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   6.549


  52 in total

1.  Cloning and tissue distribution of the human B3GALT7 gene, a member of the beta1,3-Glycosyltransferase family.

Authors:  Chaoqun Huang; Jialiang Zhou; Shiliang Wu; Yuxi Shan; Shaolei Teng; Long Yu
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

2.  Ric1-Rgp1 complex is a guanine nucleotide exchange factor for the late Golgi Rab6A GTPase and an effector of the medial Golgi Rab33B GTPase.

Authors:  Ganesh V Pusapati; Giovanni Luchetti; Suzanne R Pfeffer
Journal:  J Biol Chem       Date:  2012-10-22       Impact factor: 5.157

3.  Extended interhuman transmission of monkeypox in a hospital community in the Republic of the Congo, 2003.

Authors:  Lynne A Learned; Mary G Reynolds; Demole Wassa Wassa; Yu Li; Victoria A Olson; Kevin Karem; Linda L Stempora; Zach H Braden; Richard Kline; Anna Likos; François Libama; Henri Moudzeo; Jean Daniel Bolanda; Paul Tarangonia; Paul Boumandoki; Pierre Formenty; Joseph M Harvey; Inger K Damon
Journal:  Am J Trop Med Hyg       Date:  2005-08       Impact factor: 2.345

4.  The detection of monkeypox in humans in the Western Hemisphere.

Authors:  Kurt D Reed; John W Melski; Mary Beth Graham; Russell L Regnery; Mark J Sotir; Mark V Wegner; James J Kazmierczak; Erik J Stratman; Yu Li; Janet A Fairley; Geoffrey R Swain; Victoria A Olson; Elizabeth K Sargent; Sue C Kehl; Michael A Frace; Richard Kline; Seth L Foldy; Jeffrey P Davis; Inger K Damon
Journal:  N Engl J Med       Date:  2004-01-22       Impact factor: 91.245

5.  The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence.

Authors:  M Engelstad; G L Smith
Journal:  Virology       Date:  1993-06       Impact factor: 3.616

6.  Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans.

Authors:  Gemma C Carter; Mansun Law; Michael Hollinshead; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2005-05       Impact factor: 3.891

7.  Vaccinia extracellular virions enter cells by macropinocytosis and acid-activated membrane rupture.

Authors:  Florian Ingo Schmidt; Christopher Karl Ernst Bleck; Ari Helenius; Jason Mercer
Journal:  EMBO J       Date:  2011-07-26       Impact factor: 11.598

8.  Effects of postchallenge administration of ST-246 on dissemination of IHD-J-Luc vaccinia virus in normal mice and in immune-deficient mice reconstituted with T cells.

Authors:  Marina Zaitseva; Elisabeth Shotwell; John Scott; Stephanie Cruz; Lisa R King; Jody Manischewitz; Claudia G Diaz; Robert A Jordan; Douglas W Grosenbach; Hana Golding
Journal:  J Virol       Date:  2013-03-06       Impact factor: 6.549

9.  A retrograde trafficking inhibitor of ricin and Shiga-like toxins inhibits infection of cells by human and monkey polyomaviruses.

Authors:  Christian D S Nelson; Dan W Carney; Aaron Derdowski; Alex Lipovsky; Gretchen V Gee; Bethany O'Hara; Paul Williard; Daniel DiMaio; Jason K Sello; Walter J Atwood
Journal:  MBio       Date:  2013-11-12       Impact factor: 7.867

Review 10.  Biosynthesis and deficiencies of glycosylphosphatidylinositol.

Authors:  Taroh Kinoshita
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2014       Impact factor: 3.493

View more
  12 in total

1.  RACK1 Regulates Poxvirus Protein Synthesis Independently of Its Role in Ribosome-Based Stress Signaling.

Authors:  Chorong Park; Derek Walsh
Journal:  J Virol       Date:  2022-09-13       Impact factor: 6.549

2.  Prevention and Treatment of Monkeypox.

Authors:  John G Rizk; Giuseppe Lippi; Brandon M Henry; Donald N Forthal; Youssef Rizk
Journal:  Drugs       Date:  2022-06-28       Impact factor: 11.431

Review 3.  Perspectives on Glycosylation and Its Congenital Disorders.

Authors:  Bobby G Ng; Hudson H Freeze
Journal:  Trends Genet       Date:  2018-03-29       Impact factor: 11.639

4.  Conserved Oligomeric Golgi (COG) Complex Proteins Facilitate Orthopoxvirus Entry, Fusion and Spread.

Authors:  Susan Realegeno; Lalita Priyamvada; Amrita Kumar; Jessica B Blackburn; Claire Hartloge; Andreas S Puschnik; Suryaprakash Sambhara; Victoria A Olson; Jan E Carette; Vladimir Lupashin; Panayampalli Subbian Satheshkumar
Journal:  Viruses       Date:  2020-06-30       Impact factor: 5.048

5.  TMEM41B Is a Pan-flavivirus Host Factor.

Authors:  H-Heinrich Hoffmann; William M Schneider; Kathryn Rozen-Gagnon; Linde A Miles; Felix Schuster; Brandon Razooky; Eliana Jacobson; Xianfang Wu; Soon Yi; Charles M Rudin; Margaret R MacDonald; Laura K McMullan; John T Poirier; Charles M Rice
Journal:  Cell       Date:  2020-12-09       Impact factor: 41.582

6.  Is there a need of monkeypox vaccine amidst the hesitancy of COVID-19 immunization in Pakistan?

Authors:  Zobia Ansari; Hurriyah Ramzan; Ramsha Shakeel
Journal:  Ann Med Surg (Lond)       Date:  2022-08-23

Review 7.  Monkeypox virus: a re-emergent threat to humans.

Authors:  Qizan Gong; Changle Wang; Xia Chuai; Sandra Chiu
Journal:  Virol Sin       Date:  2022-07-09       Impact factor: 6.947

Review 8.  Monkeypox: A New Threat?

Authors:  Dorota Kmiec; Frank Kirchhoff
Journal:  Int J Mol Sci       Date:  2022-07-17       Impact factor: 6.208

Review 9.  The evolving epidemiology of monkeypox virus.

Authors:  Heng Li; Hong Zhang; Ke Ding; Xiao-Hui Wang; Gui-Yin Sun; Zhen-Xing Liu; Yang Luo
Journal:  Cytokine Growth Factor Rev       Date:  2022-10-08       Impact factor: 17.660

10.  TMEM41B is a pan-flavivirus host factor.

Authors:  H-Heinrich Hoffmann; William M Schneider; Kathryn Rozen-Gagnon; Linde A Miles; Felix Schuster; Brandon Razooky; Eliana Jacobson; Xianfang Wu; Soon Yi; Charles M Rudin; Margaret R MacDonald; Laura K McMullan; John T Poirier; Charles M Rice
Journal:  bioRxiv       Date:  2020-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.